Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: Mol Cell Neurosci. 2014 Jan 25;59:76–84. doi: 10.1016/j.mcn.2014.01.004

Table 1.

Efficiency of MACS Depletion

Cell Type Antigen Non-Depleted Depleted Percent
Depletion
T Cell CD2 70.5% 54.8% 22.3%
Monocyte CD14 57.5 0.9% 99.9%
B Cell CD19 52.2% 6% 88.5%
Stem Cell CD133 3.4% 1.6% 52.9%